Laboratorios Biogalenic S.A. DE C.V.

Laboratorios Biogalenic S.A. DE C.V. specializes in sterile pharmaceutical-grade solutions, including Sterile Water for Inhalation (USP-compliant), Sterile Water USP, and Sterile 0.9% Normal Saline USP. These products are designed for inhalation therapy and intravenous administration, ensuring compliance with USP standards for safety and efficacy.

The company is based in the United States, which means its devices are subject to U.S. medical device regulations. Since the products fall under Class II and unclassified (U) categories, they are regulated under the FDA’s framework, including pathways like the 510(k) premarket notification process for market authorization.

Laboratorios Biogalenic’s devices are listed in the FDA’s 510(k) registry, a database of medical devices that have undergone premarket notification review. This pathway is used for Class II and unclassified devices to demonstrate substantial equivalence to a legally marketed predicate, ensuring compliance before commercial distribution.

The company’s devices are classified as either Class II or unclassified (U) under U.S. medical device regulations. Class II devices generally pose moderate risk and require special controls beyond general controls, while unclassified devices are typically low-risk and may not require premarket notification if they meet specific criteria. Both classifications are determined based on their intended use and potential risks.

The FDA’s 510(k) pathway is required for Class II devices and some unclassified devices to ensure they are substantially equivalent to a legally marketed predicate device. This process involves submitting technical documentation to demonstrate that the device’s safety and effectiveness can be reasonably inferred from existing, approved products, helping regulators confirm compliance before market authorization.